3,252 hedge funds and large institutions have $222B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 586 funds opening new positions, 1,251 increasing their positions, 1,152 reducing their positions, and 85 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more repeat investments, than reductions

Existing positions increased: 1,251 | Existing positions reduced: 1,152

1% more call options, than puts

Call options by funds: $5.34B | Put options by funds: $5.26B

0.97% more ownership

Funds ownership: 66.27%67.24% (+0.97%)

Holders
3,252
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
249
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.34B
Puts
$5.26B
Net Calls
Net Calls Change

Top Buyers

1 +$610M
2 +$609M
3 +$455M
4
JP Morgan Chase
JP Morgan Chase
New York
+$375M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$323M
Name Holding Trade Value Shares
Change
Change in
Stake
2101
$993K
2102
$992K
2103
$990K
2104
$990K
2105
$989K
2106
$986K
2107
$983K
2108
$981K
2109
$980K
2110
$978K
2111
$976K
2112
$976K
2113
$976K
2114
$975K
2115
$974K
2116
$974K
2117
$973K
2118
$972K
2119
$971K
2120
$970K
2121
$970K
2122
$968K
2123
$967K
2124
$967K
2125
$966K